Who owns DRUGS MADE IN AMER ACQ II CO?
- Ticker: DMIIR
- CUSIP Number: g2851k112
Tip: Access positions for across all investors
Analyze quarterly positions in Drugs Made In Amer Acq Ii with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Drugs Made In Amer Acq Ii stock
Who bought or sold DRUGS MADE IN AMER ACQ II CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Magnetar Financial | 2.7M | $216k | 0% | Mar 2026 |
|
| Toronto-Dominion Bank | 2.7M | $216k | 100% | Mar 2026 |
|
| Vivaldi Asset Management | 2.1M | $290k | 100% | Dec 2025 |
|
| Millennium Management | 2.0M | $160k | 33% | Mar 2026 |
|
| Glazer Capital | 1.9M | $152k | 0% | Mar 2026 |
|
| Hudson Bay Capital Management | 1.7M | $136k | -13% | Mar 2026 |
|
| Polar Securities | 1.5M | $120k | 0% | Mar 2026 |
|
| Tenor Capital Management | 1.5M | $120k | 0% | Mar 2026 |
|
| Aristeia Capital | 1.4M | $108k | 23% | Mar 2026 |
|
| HGC Investment Management | 1.2M | $172k | 100% | Dec 2025 |
|
| CNH Partners | 1.2M | $93k | 1% | Mar 2026 |
|
| Davidson Kempner Capital Management | 1.0M | $80k | 0% | Mar 2026 |
|
| D. E. Shaw & Co | 1.0M | $80k | 0% | Mar 2026 |
|
| OMERS Administration Corporation | 1.0M | $80k | 0% | Mar 2026 |
|
| Jpmorgan Chase & Co | 920k | $89k | 100% | Mar 2026 |
|
| Linden Advisors | 900k | $117k | 100% | Dec 2025 |
|
| Picton Mahoney Asset Management | 875k | $70k | 0% | Mar 2026 |
|
| Context Capital Management | 750k | $60k | 0% | Mar 2026 |
|
| Mercuria Capital Strategies | 750k | $60k | 100% | Mar 2026 |
|
| Ghisallo Capital Management | 750k | $60k | 0% | Mar 2026 |
|
| Moore Capital Management | 750k | $60k | 0% | Mar 2026 |
|
| Radcliffe Capital Management | 575k | $75k | 100% | Dec 2025 |
|
| Wolverine Asset Management | 503k | $40k | 0% | Mar 2026 |
|
| HBK Investments | 500k | $40k | 0% | Mar 2026 |
|
| Meteora Capital | 481k | $38k | 701% | Mar 2026 |
|
| Whitebox Advisors | 450k | $36k | 0% | Mar 2026 |
|
| Wealthspring Capital | 403k | $32k | -2% | Mar 2026 |
|
| Commonwealth of Pennsylvania | 400k | $32k | 0% | Mar 2026 |
|
| Rivernorth Capital Management | 400k | $32k | 100% | Mar 2026 |
|
| Shaolin Capital Management | 375k | $30k | -29% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 349k | $28k | 0% | Mar 2026 |
|
| Lineage Point Capital | 330k | $26k | 0% | Mar 2026 |
|
| Alpine Partners VI | 300k | $24k | 0% | Mar 2026 |
|
| Periscope Capital | 300k | $24k | 20% | Mar 2026 |
|
| Sona Asset Management | 300k | $24k | 0% | Mar 2026 |
|
| Boothbay Fund Management | 269k | $22k | 100% | Mar 2026 |
|
| Mint Tower Capital Management B.V. | 250k | $20k | 0% | Mar 2026 |
|
| K2 Principal Fund | 250k | $35k | 100% | Dec 2025 |
|
| Verition Fund Management | 200k | $28k | 100% | Dec 2025 |
|
| Clear Street Group | 143k | $11k | 100% | Mar 2026 |
|
| DLD Asset Management | 112k | $9.0k | 0% | Mar 2026 |
|
| Centiva Capital | 100k | $8.0k | 100% | Mar 2026 |
|
| Peak6 | 100k | $8.0k | 0% | Mar 2026 |
|
| Cable Car Capital | 100k | $8.0k | 0% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 89k | $7.1k | 100% | Mar 2026 |
|
| Quarry | 81k | $11k | 100% | Dec 2025 |
|
| CSS | 81k | $65k | 0% | Mar 2026 |
|
| PenderFund Capital Management | 50k | $4.0k | 100% | Mar 2026 |
|
| Abc Arbitrage Sa | 40k | $3.2k | 0% | Mar 2026 |
|
| Robinson Capital Management | 10k | $800.000000 | 100% | Mar 2026 |
|
| Royal Bank of Canada | 7.0k | $1.0k | 100% | Mar 2026 |
|
| Highbridge Capital Management | 1.0k | $140.018800 | 100% | Dec 2025 |
|
| UBS Group | 251.00 | $20.004700 | 100% | Mar 2026 |
|
Who sold out of Drugs Made In Amer Acq Ii?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Harraden Circle Investments | Dec 2025 | 50k | $7.0k |
| Deltec Asset Management | Dec 2025 | 45k | $6.2k |